<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">healthcare</journal-id><journal-title-group><journal-title xml:lang="ru">Здравоохранение. Healthcare</journal-title><trans-title-group xml:lang="en"><trans-title>Healthcare</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-7218</issn><publisher><publisher-name>Republican Scientific and Practical Center for Medical Technologies, Informatization, Management and Health Economics</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">healthcare-205</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЛЕКЦИИ И ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LECTURES AND REVIEWS</subject></subj-group></article-categories><title-group><article-title>Молекулярные факторы формирования и развития грибковых биопленок</article-title><trans-title-group xml:lang="en"><trans-title>Molecular factors in the formation and development of fungal biofilms</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-9186-4603</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Агеев</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Aheyeu</surname><given-names>N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Агеев Николай Валентинович — младший научный сотрудник лаборатории генетических биотехнологий </p><p>Ул. Фрунзенская, 43, 223053, д. Боровляны, Минская обл. Сл. тел. +375 17 287-10-39 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-9521-2373</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черновецкий</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tchernovetski</surname><given-names>M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Черновецкий Михаил Анатольевич </p><p>Минск</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Республиканский научно-практический центр детской онкологии, гематологии и иммунологии</institution><country>Belarus</country></aff><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>22</day><month>11</month><year>2025</year></pub-date><volume>1</volume><issue>10</issue><fpage>45</fpage><lpage>54</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Агеев Н.В., Черновецкий М.А., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Агеев Н.В., Черновецкий М.А.</copyright-holder><copyright-holder xml:lang="en">Aheyeu N., Tchernovetski M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://healthcare.ejournal.by/jour/article/view/205">https://healthcare.ejournal.by/jour/article/view/205</self-uri><abstract><p>Цель обзора — осветить молекулярные механизмы образования и развития грибковых биопленок, а также перспективные методы борьбы с ними.Биопленки представляют собой форму организации сосуществования представителей одного или различных видов микроорганизмов. Под определением грибковых биопленок подразумевают сообщества, включающие микроскопических представителей царства Fungi — микромицетов.Формирование биопленки влечет за собой множество преимуществ для ее обитателей перед свободноживущими (планктонными) формами микромицетов. В состоянии биопленки клетки приобретают большую устойчивость к физико-химическим стрессовым воздействиям окружающей среды, таким как колебания температуры и кислотно-щелочного баланса. Также устойчивость к противогрибковым препаратам (антимикотикам) может возрасти на порядок, а в некоторых случаях — на несколько порядков. Кроме того, внутри биопленки микромицеты становятся труднодоступными для иммунных механизмов защиты организма-хозяина, что часто приводит к хронизации инфекционного процесса.Способность к адгезии на различных биотических и абиотических субстратах обеспечивает микроорганизмам возможность формирования биопленок как на поверхностях медицинских изделий и имплантатов (включая внутрисосудистые и мочевые катетеры, кардиальные клапанные протезы и эндопротезы суставов), так и на тканях организма-хозяина, что указывает на их ключевую роль в развитии инфекций и состояний персистирующей колонизации.Немаловажную роль в формировании биопленок и во взаимодействии микробных клеток друг с другом внутри биопленок играет «чувство кворума» (quorum sensing) — обмен сигнальными молекулами с использованием внешней среды или матрикса биопленки. В последние годы было открыто большое количество разнообразных сигнальных систем, основанных на «чувстве кворума» микромицетов, участвующих в широком спектре биологических процессов, включая образование биопленок. Учитывая, что большая часть всех видов микроорганизмов способна образовывать биопленки в естественной среде, изучение их формирования и функционирования представляет собой одно из приоритетных направлений современной микробиологии.</p></abstract><trans-abstract xml:lang="en"><p>The aim of this review is to highlight the molecular mechanisms of formation and development of fungal biofilms, as well as promising methods of combating them.Biofilms are a form of coexistence between representatives of one or, less commonly, different species of microorganisms. The term “fungal biofilms” refers to communities that include microscopic representatives of the Fungi kingdom — micromycetes.The formation of a biofilm entails many advantages for its inhabitants over free-living (planktonic) forms of micromycetes. In the biofilm state, cells acquire greater resistance to physical and chemical stress factors in the environment, such as temperature fluctuations and acid-base balance. In addition, resistance to antifungal drugs (antimycotics) can increase by an order of magnitude, and in some cases by several orders of magnitude. Furthermore, within the biofilm, micromycetes become difficult to reach for the immune defence mechanisms of the host organism, which often leads to the chronicity of the infectious process.The ability to adhere to various biotic and abiotic substrates allows microorganisms to form biofilms on the surfaces of medical devices and implants (including intravascular and urinary catheters, cardiac valve prostheses and joint endoprostheses) and on the tissues of the host organism, indicating their key role in the development of infections and persistent colonisation.Quorum sensing, the exchange of signalling molecules using the external environment or biofilm matrix, plays an important role in biofilm formation and in the interaction of microbial cells with each other within biofilms. In recent years, a large number of diverse signalling systems based on the quorum sensing of micromycetes have been discovered, which are involved in a wide range of biological processes, including biofilm formation. Given that most microorganisms are capable of forming biofilms in their natural environment, studying their formation and functioning is one of the priority areas of modern microbiology.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>грибковые инфекции</kwd><kwd>микозы</kwd><kwd>«чувство кворума»</kwd><kwd>биопленки</kwd><kwd>микромицеты</kwd><kwd>молекулярные механизмы биопленкообразования</kwd></kwd-group><kwd-group xml:lang="en"><kwd>fungal infections</kwd><kwd>mycoses</kwd><kwd>quorum sensing</kwd><kwd>biofilms</kwd><kwd>micromycetes</kwd><kwd>molecular mechanisms of biofilm formation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Fungal biofilm formation and its regulatory mechanism / D. Wang, N. Zeng, Ch. Li [et al.] // Heliyon. — 2024. — Vol. 10, № 12. — DOI: 10.1016/j.heliyon.2024.e32766.</mixed-citation><mixed-citation xml:lang="en">Fungal biofilm formation and its regulatory mechanism / D. Wang, N. Zeng, Ch. Li [et al.] // Heliyon. — 2024. — Vol. 10, № 12. — DOI: 10.1016/j.heliyon.2024.e32766.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Highlights in pathogenic fungal biofilms / J. D. C. O. Sardi, N. De S. Pitangui, G. Rodriguez-Arellanes [et al.] // Revista Iberoamericana de Micologia. — 2014. — Vol. 31, № 1. — P. 22—29.</mixed-citation><mixed-citation xml:lang="en">Highlights in pathogenic fungal biofilms / J. D. C. O. Sardi, N. De S. Pitangui, G. Rodriguez-Arellanes [et al.] // Revista Iberoamericana de Micologia. — 2014. — Vol. 31, № 1. — P. 22—29.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Davies, D. Understanding biofilm resistance to antibacterial agents / D. Davies // Nature Reviews Drug Discovery. — 2003. — Vol. 2, № 2. — P. 114—122.</mixed-citation><mixed-citation xml:lang="en">Davies, D. Understanding biofilm resistance to antibacterial agents / D. Davies // Nature Reviews Drug Discovery. — 2003. — Vol. 2, № 2. — P. 114—122.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Production of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development / M. A. S. Alem, M. D. Y. Oteef, T. H. Flowers, L. J. Douglas // Eukaryotic Cell. — 2006. — Vol. 5, № 10. — P. 1770—1779.</mixed-citation><mixed-citation xml:lang="en">Production of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development / M. A. S. Alem, M. D. Y. Oteef, T. H. Flowers, L. J. Douglas // Eukaryotic Cell. — 2006. — Vol. 5, № 10. — P. 1770—1779.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Quorum Sensing in Fungal Species / X. Tian, H. Ding, W. Ke, L. Wang // Annual Review of Microbiology. — 2021. — Vol. 75, № 1. — P. 449—469.</mixed-citation><mixed-citation xml:lang="en">Quorum Sensing in Fungal Species / X. Tian, H. Ding, W. Ke, L. Wang // Annual Review of Microbiology. — 2021. — Vol. 75, № 1. — P. 449—469.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cavalheiro, M. Candida Biofilms: threats, challenges, and promising strategies / M. Cavalheiro, M. C. Teixeira // Frontiers of Medicine. — 2018. — Vol. 5. — DOI: 10.3389/FMED.2018.00028.</mixed-citation><mixed-citation xml:lang="en">Cavalheiro, M. Candida Biofilms: threats, challenges, and promising strategies / M. Cavalheiro, M. C. Teixeira // Frontiers of Medicine. — 2018. — Vol. 5. — DOI: 10.3389/FMED.2018.00028.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">The APSES transcription factor Efg1 is a global regulator that controls morphogenesis and biofilm formation in Candida parapsilosis / L. A. Connolly, Al. Riccombeni, Z. Grozer [et al.] // Molecular Microbiology. — 2013. — Vol. 90, № 1. — С. 36—53.</mixed-citation><mixed-citation xml:lang="en">The APSES transcription factor Efg1 is a global regulator that controls morphogenesis and biofilm formation in Candida parapsilosis / L. A. Connolly, Al. Riccombeni, Z. Grozer [et al.] // Molecular Microbiology. — 2013. — Vol. 90, № 1. — С. 36—53.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans / G. Ramage, K. VandeWalle, J. L. Lopez-Ribot, B. L. Wickes // FEMS Microbiology Letters. — 2002. — Vol. 214, № 1. — P. 95—100.</mixed-citation><mixed-citation xml:lang="en">The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans / G. Ramage, K. VandeWalle, J. L. Lopez-Ribot, B. L. Wickes // FEMS Microbiology Letters. — 2002. — Vol. 214, № 1. — P. 95—100.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">In vitro long-term exposure to chlorhexidine or triclosan induces cross-resistance against azoles in Nakaseomyces glabratus / K. Spettel, D. Bumberger, R. Kriz [et al.] // Antimicrobial Resistance and Infection Control. — 2025. — Vol. 14, № 1. — DOI: 10.1186/s13756-024-01511-4.</mixed-citation><mixed-citation xml:lang="en">In vitro long-term exposure to chlorhexidine or triclosan induces cross-resistance against azoles in Nakaseomyces glabratus / K. Spettel, D. Bumberger, R. Kriz [et al.] // Antimicrobial Resistance and Infection Control. — 2025. — Vol. 14, № 1. — DOI: 10.1186/s13756-024-01511-4.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">The Membrane Activity of the Amphibian Temporin B Peptide Analog TB_KKG6K Sheds Light on the Mechanism That Kills Candida albicans / A. Kakar, L. E. Sastre-Velasquez, M. Hess [et al.] // mSphere. — 2022. — Vol. 7, № 5. — P. 1—20.</mixed-citation><mixed-citation xml:lang="en">The Membrane Activity of the Amphibian Temporin B Peptide Analog TB_KKG6K Sheds Light on the Mechanism That Kills Candida albicans / A. Kakar, L. E. Sastre-Velasquez, M. Hess [et al.] // mSphere. — 2022. — Vol. 7, № 5. — P. 1—20.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of Klebsiella pneumoniae Clinical Isolates to Chlorhexidine / M. E. Wand, L. J. Bock, L. C. Bonney, J. M. Sutton // Antimicrobial Agents and Chemotherapy. — 2017. — Vol. 61, № 1. — P. 1—16.</mixed-citation><mixed-citation xml:lang="en">Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of Klebsiella pneumoniae Clinical Isolates to Chlorhexidine / M. E. Wand, L. J. Bock, L. C. Bonney, J. M. Sutton // Antimicrobial Agents and Chemotherapy. — 2017. — Vol. 61, № 1. — P. 1—16.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Berman, J. Drug resistance and tolerance in fungi / J. Berman, D. J. Krysan // Nature Reviews Microbiology. — 2020. — Vol. 18, № 6. — P. 319—331.</mixed-citation><mixed-citation xml:lang="en">Berman, J. Drug resistance and tolerance in fungi / J. Berman, D. J. Krysan // Nature Reviews Microbiology. — 2020. — Vol. 18, № 6. — P. 319—331.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">WHO fungal priority pathogens list to guide research, development and public health action. — Geneva : World Health Organization, 2022. — 48 p.</mixed-citation><mixed-citation xml:lang="en">WHO fungal priority pathogens list to guide research, development and public health action. — Geneva : World Health Organization, 2022. — 48 p.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Biofilms and Antifungal Resistance / E. P. Fox, N. Hartooni, C. J. Nobile, Sh. D. Singh-Babak’s // Antifungals: From Genomics to Resistance and the Development of Novel Agents. — Caister Academic Press, 2015. — P. 71—90. — DOI:10.21775/9781910190012.04.</mixed-citation><mixed-citation xml:lang="en">Biofilms and Antifungal Resistance / E. P. Fox, N. Hartooni, C. J. Nobile, Sh. D. Singh-Babak’s // Antifungals: From Genomics to Resistance and the Development of Novel Agents. — Caister Academic Press, 2015. — P. 71—90. — DOI:10.21775/9781910190012.04.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Putative role of beta-1,3 glucans in Candida albicans biofilm resistance / J. Nett, L. Lincoln, K. Marchillo [et al.] // Antimicrobial Agents and Chemotherapy. — 2007. — Vol. 51, № 2. — P. 510—520.</mixed-citation><mixed-citation xml:lang="en">Putative role of beta-1,3 glucans in Candida albicans biofilm resistance / J. Nett, L. Lincoln, K. Marchillo [et al.] // Antimicrobial Agents and Chemotherapy. — 2007. — Vol. 51, № 2. — P. 510—520.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Role of matrix β-1,3 glucan in antifungal resistance of non-albicans Candida biofilms / K. F. Mitchell, H. T. Taff, M. A. Cuevas [et al.] // Antimicrobial Agents and Chemotherapy. — 2013. — Vol. 57, № 4. — P. 1918—1920.</mixed-citation><mixed-citation xml:lang="en">Role of matrix β-1,3 glucan in antifungal resistance of non-albicans Candida biofilms / K. F. Mitchell, H. T. Taff, M. A. Cuevas [et al.] // Antimicrobial Agents and Chemotherapy. — 2013. — Vol. 57, № 4. — P. 1918—1920.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Garvey, M. Pathogenic drug resistant fungi : a review of mitigation strategies / M. Garvey, N. J. Rowan // International Journal of Molecular Sciences. — 2023. — Vol. 24, № 2. — DOI: 10.3390/ijms24021584.</mixed-citation><mixed-citation xml:lang="en">Garvey, M. Pathogenic drug resistant fungi : a review of mitigation strategies / M. Garvey, N. J. Rowan // International Journal of Molecular Sciences. — 2023. — Vol. 24, № 2. — DOI: 10.3390/ijms24021584.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
